SCHEMBL6582142

SCHEMBL6582142

CCOC(=O)CCCOc1ccc(C(=O)OCC)cc1C

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.53
KMT2A Q03164 1/20 0.53
L3MBTL1 Q9Y468 1/20 0.50
THRA P10827 1/20 0.49
THRB P10828 1/20 0.49
CA12 O43570 2/20 0.48
CA1 P00915 2/20 0.48
CA2 P00918 2/20 0.48
CA7 P43166 2/20 0.48
CA9 Q16790 2/20 0.48
CA14 Q9ULX7 2/20 0.48
HSD17B2 P37059 1/20 0.47
GAA P10253 1/20 0.45
TAS1R3 Q7RTX0 2/20 0.45
TAS1R1 Q7RTX1 2/20 0.45
KDM4E B2RXH2 1/20 0.45
TP53 P04637 1/20 0.45
ALOX15 P16050 1/20 0.45
PDE4A P27815 1/20 0.44
PDE4B Q07343 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10102465 0.86 CA12 (0.50) MEN1KMT2AL3MBTL1THRATHRB
SCHEMBL12493300 0.84 TAS1R3 (0.60) CA12CA1CA2CA7CA9
SCHEMBL4328843 0.83 CA12 (0.55) MEN1KMT2AL3MBTL1CA12CA1
SCHEMBL1613775 0.82 MEN1 (0.76) MEN1KMT2AGAAKDM4ETP53
SCHEMBL29351129 0.82 MEN1 (0.76) MEN1KMT2AGAAKDM4ETP53
SCHEMBL642682 0.82 HSD17B2 (0.56) MEN1KMT2AHSD17B2GAAPDE4A
SCHEMBL4344594 0.82 HSD17B2 (0.56) MEN1KMT2ATHRATHRBHSD17B2
SCHEMBL10118736 0.81 CA12 (0.59) MEN1KMT2AL3MBTL1CA12CA1
SCHEMBL642011 0.80 HSD17B2 (0.47) L3MBTL1THRATHRBHSD17B2TP53
SCHEMBL9174312 0.80 ALDH1A1 (0.46) MEN1KMT2AL3MBTL1THRATHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0784052-B1 Quinoline derivatives as antagonists of leukotriene d4, compositions containing the same and processes for their preparation AVENTIS HOLDINGS INC (US) 2004-09-01 EP disclosed